CLASRP and colorectal carcinoma: Furthermore, the levels of Bcl-XL decreased at 48 h in CLASRP-overexpressing DLD-1 cells treated with the inhibitors TG003 and KH-CB19, suggesting that Clk inhibitors could successfully induce apoptosis in CRC cells overexpressing CLASRP.